Optimizing Outcomes in Generalized Pustular Psoriasis With IL-36 Antagonists
Practical strategies to optimize diagnosis of generalized pustular psoriasis, looking at the latest clinical evidence evaluating targeted treatments.
While there are no treatments specific to generalized pustular psoriasis, knowledge about disease pathogenesis is evolving, with IL-36 emerging a major drivers of disease. Join us as we discuss the latest evidence evaluating targeted treatments for challenging disease.
To register go to